Embla Medical hf (OTCPK:OSSUY)
$ 9 0 (0%) Market Cap: 1.78 Bil Enterprise Value: 2.26 Bil PE Ratio: 66.67 PB Ratio: 4.95 GF Score: 69/100

Q1 2019 Ossur hf Earnings Call Transcript

Apr 30, 2019 / 07:00AM GMT
Release Date Price: $4.65
Operator

Ladies and gentlemen, welcome to the Ãssur Q1 Results 2019 Conference Call. Today, I'm pleased to present Mr. Jón Sigurdsson, President and CEO; and Mr. Sveinn Sölvason, CFO. (Operator Instructions) Speakers, please begin.

Jón Sigurdsson;ssur hf.;CEO;President
Ã

&

Thank you. I would like to welcome you to the Ãssur investor conference call where we will cover the results for the first quarter of 2019.

As previously mentioned, my name is Jón Sigurdsson and I'm the President and CEO, and with me here today is Sveinn Sölvason, the CFO.

We will begin by going through the highlights of the quarter and then end with our guidance for 2019 followed by a question-and-answer session.

Sales in the first quarter of the year amounted to $160 million, corresponding to 19% growth in local currency, 8% organic growth and 13% reported growth in U.S. dollars. The prosthetics segment grew 10% organic and the bracing and supports segment grew 5%. EBITDA grew 51% and amounted to $30 million or 19

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot